Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-07-07-Speech-3-506"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20100707.32.3-506"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"It is important to prepare well for this crucial conference, especially with a view to how to reduce the enormous cost of pills administered to affected parties. In Malta, the importers of medicinal products and the Nationalist Parliamentary Secretary have agreed to reduce the price of 63 medicinal products. It is astounding when there are over 3 000 medicinal products that are distributed in Malta. This means that only 2% have actually been targeted. Amongst the medicines which have been reduced in price, two were taken as examples forwarded to the Commission comparing the exorbitant prices in Malta and Belgium. Zocor 20mg has been reduced, but it is still 240% more expensive in Malta than it is in Belgium. From the other examples provided, all remain more expensive in Malta, the highest being Tegretol 200 mg, which is 150% higher in price, and Lexotan 3 mg – 113% higher. The lowest is Actonel 35, which is 20% higher in Malta. The fact that medicines have started to decrease in price, although not enough, only illustrates how right we have been not to accept the excuses put forward by a number of medicine providers. Let us hope that this is only the beginning in achieving our aim."@en1
|
lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples